The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

We use cookies to improve your experience and serve personalized ads.

By clicking Accept, you consent to our use of advertising cookies. See our Privacy Policy for details.

Stocks•21 April 2026•

1 min read

OCI Global Completes Divestment of Remaining Stake in Methanex Corporation

FDA and Novo Nordisk logos above a laboratory scene with computer monitors, chemical structures, medicine bottles, and pills.

Key Facts

1OCI Global's subsidiary, OCI Chemicals B.V., sold 2,612,962 common shares of Methanex Corporation.

2The sold shares represent approximately 3.4% of the issued and outstanding shares of Methanex.

OCI Global has announced the completion of the sale of its remaining equity stake in Methanex Corporation through its subsidiary, OCI Chemicals B.V. The transaction involved the sale of 2,612,962 common shares, representing approximately 3.4% of Methanex's total issued and outstanding shares. This divestment is part of OCI Global's broader strategy for financial management and portfolio optimization. With this move, the company has fully exited its position in Methanex to focus on other strategic priorities. The sale is viewed as a step toward strengthening OCI's balance sheet and streamlining its investment holdings. No immediate material changes to the operational activities of either company are expected following the transaction. This exit underscores a continuing trend of portfolio restructuring within the global chemicals sector.